Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Aprea Therapeutics Inc.

    NASDAQ: APRE · Real-Time Price · USD
    1.58
    -0.01 (-0.63%)
    At close: Aug 20, 2025, 1:25 PM

    Aprea Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 1.5M 583.23K n/a n/a
    Cost of Revenue
    		 22.32K 7.05K 186.44K 271.68K
    Gross Profit
    		 1.48M 576.18K -186.44K -271.68K
    Operating Income
    		 -14.32M -15.47M -37.37M -37.45M
    Interest Income
    		 1.29M 1.22M 448.67K 1.65K
    Pretax Income
    		 -12.96M -14.29M -112.66M -37.13M
    Net Income
    		 -12.96M -14.29M -224.88M -36.54M
    Selling & General & Admin
    		 6.46M 8.42M 20.97M 13.55M
    Research & Development
    		 9.36M 7.63M 16.4M 23.9M
    Other Expenses
    		 n/a n/a n/a -271.68K
    Operating Expenses
    		 15.82M 16.05M 37.37M 37.17M
    Interest Expense
    		 n/a n/a 448.67K n/a
    Selling & Marketing Expenses
    		 n/a -7.05K n/a n/a
    Cost & Expenses
    		 15.82M 16.06M 37.37M 37.45M
    Income Tax Expense
    		 n/a n/a 112.21M -590.73K
    Shares Outstanding (Basic)
    		 5.51M 3.62M 82.85K 1.06M
    Shares Outstanding (Diluted)
    		 5.51M 3.62M 82.85K 1.06M
    EPS (Basic)
    		 -2.35 -3.95 -1.36K -34.88
    EPS (Diluted)
    		 -2.35 -3.95 -1.36K -34.88
    EBITDA
    		 -12.94M -14.28M -112.48M -36.86M
    EBIT
    		 -12.96M -14.29M -112.66M -37.13M
    Depreciation & Amortization
    		 22.32K 7.05K 186.44K 271.68K

    Add to Watchlist